Background The systemic immune-inflammation index (SII), calculated using absolute
platelet, neutrophil, and lymphocyte counts, has recently emerged as a predictor of survival …

Objective: Our aim was to determine the prognostic significance of the systemic-immune-
inflammation index (SIII) in patients with resectable pancreatic cancer, using cancer-specific …

Background: Systemic immune-inflammation index (SII) is a prognostic indicator for several
malignancies, including pancreatic carcinoma; however, there is no consensus on its …

Purpose: The systemic inflammation response index (SIRI), based on peripheral neutrophil,
monocyte, and lymphocyte counts, was recently emerged and used as a novel tool in …

Background The systemic immune-inflammation index based on peripheral neutrophil,
lymphocyte, and platelet counts has shown a prognostic impact in several malignancies …

Background Pancreatic ductal adenocarcinoma (PDAC) detains a dismal prognosis and has
a limited number of prognostic factors. Inflammation has been demonstrated to play a key …

Background Systemic inflammatory markers are associated with patient survival in
pancreatic cancer (PC). The aim of this study was to investigate the prognostic significance …

Background Systemic inflammation and immune dysfunction have been proved to be
associated with cancer progression and metastasis in various malignancies. The aim of this …

The systemic immune-inflammation index (SII) is a significant prognostic factor in some
cancer types. However, the prognostic value of SII in patients with pancreatic cancer (PC) …

Backgrounds/Aims It is important to point out that the identification of inflammation is an
essential component of the pathogenesis and the progression of cancer. In this study, we …